Skip to main content

Table 2 Comparison of IMP3 expression in different lymphoma subtype

From: The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma

Lymphoma type

Intensity of IMP3 expression

Total

Negativea

Variable )weak to moderate)

Strong above 55%

LBCL- subtype

THRLBCL

2

4

10

16

DLBCL,NOS

0

1

11

12

NLPHL

3

22

3

28

  1. aModerate to strong staining in at least 10% of tumor cells was considered positive IMP3 expression and remaining was defined as negative. DLBCL NOS vs. THRLBCL p = 0.188; DLBCL NOS vs. NLPHL p < 0.001 ; THRLBCL vs. NLPHL p < 0.001 ; LBCL (THRLBCL + DLBCL NOS) vs NLPHL p < 0.001
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us